Hikma adds scale to US injectables business with Xellia acquisition
(Alliance News) - Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmark's Xellia Pharmaceuticals ApS. Read More
Price | 1,896.00p on 26-07-2024 | at 16:30:01
---|---|
Change | 34.00p 1.83% |
Buy | 1,889.00p |
Sell | 1,888.00p |
Buy / Sell HIK Shares |
Last Trade: | Sell 4,118.00 at 1,885.2365p |
Day's Volume: | 216,925 |
Last Close: | 1,896.00p |
Open: | 1,863.00p |
ISIN: | GB00B0LCW083 |
Day's Range | 1,855.00p - 1,896.00p |
52wk Range: | 1,711.00p - 2,222.00p |
Market Capitalisation: | £4,207m |
VWAP: | 1,887.80605p |
Shares in Issue: | 222m |
Recent Trades History Hikma Pharmaceuticals (HIK) |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 4,118 | 1,885.2365p | Negotiated Trade |
15:41:39 - 26-Jul-24 |
Unknown* | -4,118 | 1,885.2365p | Correction Negotiated Trade |
15:41:39 - 26-Jul-24 |
Sell* | 504 | 1,885.2365p | Negotiated Trade |
15:41:46 - 26-Jul-24 |
Sell* | 1,762 | 1,885.2365p | Negotiated Trade |
15:41:43 - 26-Jul-24 |
Sell* | 1,341 | 1,885.2365p | Negotiated Trade |
15:41:41 - 26-Jul-24 |
Sell* | 4,118 | 1,885.2365p | Negotiated Trade |
15:41:39 - 26-Jul-24 |
Sell* | 136 | 1,885.2365p | Negotiated Trade |
15:41:36 - 26-Jul-24 |
Sell* | 5,622 | 1,885.2365p | Negotiated Trade |
15:41:33 - 26-Jul-24 |
Sell* | 3,431 | 1,885.2365p | Negotiated Trade |
15:41:30 - 26-Jul-24 |
Buy* | 127,744 | 1,896.00p | Suspected BUY Trade |
15:35:00 - 26-Jul-24 |